Dermatan sulfate-low molecular weight - MediolanumAlternative Names: MF 777
Latest Information Update: 28 May 2007
At a glance
- Originator Mediolanum
- Class Antithrombotics
- Mechanism of Action Glycosaminoglycan stimulants; Thrombin inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Venous thrombosis
Most Recent Events
- 28 Mar 2000 Preclinical development for Venous thrombosis in Italy (Unknown route)